Risk stratification of stage II rectal mucinous adenocarcinoma to predict the benefit of adjuvant chemotherapy following neoadjuvant chemoradiation and surgery

Overview of attention for article published in Frontiers in oncology, March 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 3 X users

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 37,621 followers.

Risk stratification of stage II rectal mucinous adenocarcinoma to predict the benefit of adjuvant chemotherapy following neoadjuvant chemoradiation and surgery: Background The treatment strategy for stage II rectal mucinous… … #oncology https://t.co/olUgJ

08 Mar 2024

Reply Repost Favourite

RT @FrontOncology: New research: Risk stratification of stage II rectal mucinous adenocarcinoma to predict the benefit of adjuvant chemothe…

05 Mar 2024

Reply Repost Favourite

New research: Risk stratification of stage II rectal mucinous adenocarcinoma to predict the benefit of adjuvant chemotherapy following neoadjuvant chemoradiation and surgery: Background The treatment strategy for stage II rectal mucinous… https://t.co/c1Y

05 Mar 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.